Is Anti-IL 5 Therapy Effective in Eosinophilic Granulomatosis With Polyangiitis?

Synopsis: In patients with EGPA who are glucocorticoid dependent, use of mepolizumab decreased the use of glucocorticoids and increased rates of remission compared with placebo.
Source: Wechsler ME, Akuthota P, Jayne D, et al. Mepolizumab or placebo for eosinophilic granulomatosis with polyangiitis. N Engl J Med 2017; 376:1921–932.

Source: Clinical Pulmonary Medicine - November 1, 2017 Category: Respiratory Medicine Tags: Pulmonary Trends Source Type: research